drugset / Trial / NCT01625871

Artemether/Lumefantrine and Vivax Malaria

NCT01625871

NaSingle-groupOpen-labelTreatment

Summary

The cure rate of artemether/lumefantrine in the treatment of vivax malaria.

Timeline

Start
2011-09
Primary completion
2012-09
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Artemether Small molecule 20 mg Oral
Subject lumefantrine Small molecule 120 mg Oral